Leading Malaysian Genome Resource Center for Genomics and Biopharmaceutics (MGRC) Berhad has signed a Letter of Intent (LOI) with the College of Science and Natural Resources, University of Malaysia Sabah (UMS) and Renani Genotech SDN Bhd. ) in genetics and renewable and alternative medicines.
Under the LOI, MGRC, which has a high-throughput sequencing lab, a state-of-the-art microarray facility, and a new state-of-the-art cell processing laboratory, as well as Genotec, which specializes in biomedical therapies using stem cells, will help strengthen the teaching and research activities of the undergraduate program in the College of Science and Natural Resources at UMS.
This collaboration will enable the exchange of research resources and ideas to enhance the quality of research at UMS, as well as create opportunities for students from the College of Science and Natural Resources to serve their internship at MGRC or Genotec.Read:Mac Jones’ return timetable could take ‘more than a month,’ according to sports medicine doctor
Head of Department of Genomics Malaysia, Datuk Seri Dr. Chen Chau Min said, “We are pleased to help UMS undergraduate students pursue their research and development goals so that they have a better understanding of their field of study. This also supports the recently launched National Biotechnology Policy 2.0 with a focus on agriculture. food security, health care and welfare, as well as an industrial and circular economy.”
The signing of the LOI came on the heels of a visit by UMS to the MGRC Biosafety Level 2 cGMP (Current Good Manufacturing Practices) laboratory, which is used to produce cell therapies, including CAR T-cell therapies for various types of cancer.
Read:Heart failure risk rises 10% for every inch you can pinch | News